ESPR icon

Esperion Therapeutics
ESPR

Overview Fund Activity

152 hedge funds and large institutions have $336M invested in Esperion Therapeutics in 2024 Q1 according to their latest regulatory filings, with 43 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 21 closing their positions.

Holders
152
Holders Change
+21
Holders Change %
+16.03%
% of All Funds
2.2%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
43
Increased
46
Reduced
29
Closed
21
Calls
$8.22M
Puts
$3.49M
Net Calls
+$4.72M
Net Calls Change
-$3.15M

Top Buyers

1
O
1
OrbiMed
New York
$36.7M
2
GPP
2
Great Point Partners
Connecticut
$21.4M
3
WP
3
Woodline Partners
California
$21.2M
4
BG
4
Bellevue Group
Switzerland
$26.7M
5
Bank of America
5
Bank of America
North Carolina
$12.2M

Top Sellers

1
AC
1
Armistice Capital
New York
$0
2
TSC
2
Two Seas Capital
New York
$11.2M
3
TCM
3
Tang Capital Management
California
$0
4
PIM
4
Platinum Investment Management
Australia
$4.28M
5
WCM
5
Whitefort Capital Management
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
O
1
OrbiMed
New York
$36.7M 13,708,731 +13,708,731 New
BG
2
Bellevue Group
Switzerland
$26.7M 9,944,064 +5,739,800 +137%
WA
3
Wasatch Advisors
Utah
$24.5M 9,129,647 +238,544 +3%
Vanguard Group
4
Vanguard Group
Pennsylvania
$23.7M 8,826,546 +3,688,796 +72%
GPP
5
Great Point Partners
Connecticut
$21.4M 8,000,000 +8,000,000 New
WP
6
Woodline Partners
California
$21.2M 7,922,229 +7,631,847 +2,628%
Millennium Management
7
Millennium Management
New York
$15.2M 5,681,744 +2,232,293 +65%
D.E. Shaw & Co
8
D.E. Shaw & Co
New York
$13.8M 5,143,486 +3,930,283 +324%
Bank of America
9
Bank of America
North Carolina
$12.2M 4,545,260 +4,368,724 +2,475%
TSC
10
Two Seas Capital
New York
$11.2M 4,165,657 -3,520,463 -46%
Two Sigma Investments
11
Two Sigma Investments
New York
$10.7M 3,975,560 +1,641,150 +70%
MG
12
Meditor Group
Bermuda
$10.2M 3,791,300 – –
Two Sigma Advisers
13
Two Sigma Advisers
New York
$9.57M 3,569,700 +1,423,100 +66%
Goldman Sachs
14
Goldman Sachs
New York
$9.02M 3,364,266 +2,306,865 +218%
Citadel Advisors
15
Citadel Advisors
Florida
$9.01M 3,362,210 +2,899,928 +627%
BlackRock
16
BlackRock
New York
$7.61M 2,838,820 +725,921 +34%
Marshall Wace
17
Marshall Wace
United Kingdom
$5.94M 2,215,961 +1,758,203 +384%
Renaissance Technologies
18
Renaissance Technologies
New York
$5.67M 2,116,500 +696,400 +49%
JPMorgan Chase & Co
19
JPMorgan Chase & Co
New York
$5.59M 2,085,101 +222,631 +12%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$5.48M 2,045,769 +655,495 +47%
Geode Capital Management
21
Geode Capital Management
Massachusetts
$4.7M 1,753,193 +640,947 +58%
Morgan Stanley
22
Morgan Stanley
New York
$4.4M 1,642,360 -567,640 -26%
Qube Research & Technologies (QRT)
23
Qube Research & Technologies (QRT)
United Kingdom
$4.31M 1,607,312 +1,172,071 +269%
PIM
24
Platinum Investment Management
Australia
$4.28M 1,597,542 -1,213,013 -43%
PHP
25
Parkman Healthcare Partners
Connecticut
$3.06M 1,142,897 -282,307 -20%
1
2 3 4 5